This week, a post about the death of white-collar jobs rocks Silicon Valley and Elon Musk shifts his space plans a little closer to home.
HELUS Pharma Reports Third Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights
Cash position of US$195 million as of December 31, 2025, before adjustment for post quarter events -- Topline data readout from the Phase 2 study evaluating HLP004 in generalized anxiety disorder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results